AVATAR MEDICAL Elodie Brient-Litzler has 15 years of R&D and innovation experience at the intersection of math/physics/chemistry and biology/medicine. She is well-versed in transitioning science from academia into products for the industry. She started her career as a scientist within the French engineering company Bertin Technologies, working on biodetection technologies. She returned to academia and joined Andrew Griffiths’ microfluidics laboratory at ESPCI, where she established and managed public-private R&D projects including the €20 million national “DigiDiag” project dedicated to diagnostics technology. She was an active participant in the launch of several start-ups such as HiFiBiO. She joined Institut Pasteur in 2015 as deputy CTO in charge of operations, where she fostered the adoption and dissemination of innovative technologies, and managed/reorganized the 150 pers. core facilities. She later moved to the Innovation Office of Institut Pasteur after its creation in 2018. There, she helped to structure a number of academic projects into product prototypes, such as the DIVA image analysis project which led to the creation of AVATAR MEDICAL in 2020. She joined the spin-off company as COO, and was also in charge of the regulatory, leading to the FDA approval of the first product in Q2 2023.
She holds a doctorate in biochemistry from Université Pierre et Marie Curie (today Sorbonne Université) and engineering degrees from Ecole Polytechnique and Chimie Paristech, Paris, France.
